Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab

Annals of Allergy, Asthma and Immunology

Volumn 108, Issue 5, 2012, Pages 383-384

  Bell, Matthew C ^a   Jackson, Daniel J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CETIRIZINE; CORTICOSTEROID; LORATADINE; OMALIZUMAB; RANITIDINE;

ABDOMINAL PAIN; ANAPHYLAXIS; BLACKBERRY; CASE REPORT; CHERRY; CHILD; DIARRHEA; DRUG WITHDRAWAL; DYSPNEA; ECZEMA; FATIGUE; FLUSHING; HEADACHE; HUMAN; HYPERSENSITIVITY; LABORATORY TEST; LETTER; MALE; MAST CELL ACTIVATION SYNDROME; MEDICAL HISTORY; PRICK TEST; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; URTICARIA; WHEEZING;

EID: 84860358643     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.02.021     Document Type: Article

References (8)

1. C. Akin, P. Valent, D.D. Metcalfe Mast cell activation syndrome: proposed diagnostic criteria J Allergy Clin Immunol 126 2010 1099 1104
2. G.J. Molderings, S. Brettner, J. Homann, L.B. Afrin Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options J Hematol Oncol 4 2011 10
3. R. Sargur, D. Cowley, S. Murng Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay Clin Exp Immunol 163 2011 339 345
4. G.J. Molderings, M. Raithel, F. Kratz Omalizumab treatment of systemic mast cell activation disease: experiences from four cases Intern Med 50 2011 611 615
5. J.A. Douglass, K. Carroll, A. Voskamp, P. Bourke, A. Wei, R.E. O'Hehir Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient Allergy 65 2010 926 927
6. M.C. Carter, J.A. Robyn, P.B. Bressler, J.C. Walker, G.G. Shapiro, D.D. Metcalfe Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis J Allergy Clin Immunol 119 2007 1550 1551
7. T.W. Chang, Y.Y. Shiung Anti-IgE as a mast cell-stabilizing therapeutic agent J Allergy Clin Immunol 117 2006 1203 1212
8. T.C. Theoharides, D. Kempuraj, M. Tagen, P. Conti, D. Kalogeromitros Differential release of mast cell mediators and the pathogenesis of inflammation Immunol Rev 217 2007 65 78